OCCULO HOLDINGS
OCCULO HOLDINGS
Industry:
Biotechnology
Founded:
2016-10-21
Address:
Lebanon, New Hampshire, United States
Country:
United States
Website Url:
http://www.occulobio.com
Total Employee:
1+
Status:
Closed
Contact:
603-359-2463
Total Funding:
12.8 M USD
Technology used in webpage:
Domain Not Resolving
Current Employees Featured
Founder
More informations about "Occulo Holdings"
Occulo Holdings Company Profile - Office Locations, Competitors โฆ
Occulo Holdings $12.8 m in total funding,. See insights on Occulo Holdings including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Occulo Holdings - Crunchbase Company Profile & Funding
Occulo Holdings is a biotechnology company. When was the last funding round for Occulo Holdings? Occulo Holdings closed its last funding round on Nov 17, 2017 from a Venture - โฆSee details»
Occulo Bio LLC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Occulo Bio LLC of Lebanon, NH. Get the latest business insights from Dun & Bradstreet. Occulo Bio LLC. โฆSee details»
Occulo Bio LLC Overview | SignalHire Company Profile
Organization Website: occulobio.com : Occulo Bio LLC industries Biotech: Headquarters Location: 16 Cavendish Ct, Lebanon, New Hampshire, 03766 US 16 Cavendish Ct, Lebanon, N...See details»
Occulo Bio - Products, Competitors, Financials, Employees, โฆ
Headquarters Location. 16 Cavendish Court . Lebanon, New Hampshire, 03766, United States. 603-359-2463See details»
Occulo - Company Profile - Tracxn
Oct 23, 2024 Its family includes OcculoBio, Stealth Biologics and Lyticon. The company has a proprietary technology which combines advanced computational models, protein design โฆSee details»
Occulo Holdings CEO and Key Executive Team | Craft.co
Occulo Holdings's Co-Founder and CEO is Karl Griswold. Other executives include Yongliang Fang, Co-Founder and COO; Chris Bailey-Kellogg, Co-Founder and CTO. See the full โฆSee details»
OCCULO BIO LLC | New Hampshire Company Directory
OCCULO BIO LLC was registered on Jan 26 2018 as a foreign limited liability company type with the address 16 Cavendish Ct. Rm 229, Lebanon, NH, 03766, USA . The business id is โฆSee details»
Occulo - VentureRadar
LucasPye Bio USA n/a As a Contract Development Manufacturing Organization (CDMO), we fast-track the clinical development of your biologic for regulatory approval, manufacture your โฆSee details»
Occulo Bio LLC - Company Profile & Staff Directory - ContactOut
Discover Occulo Bio LLC company details, including staff directory, contact information, and industry insights. Explore alternatives, competitors, and frequently asked questions to get โฆSee details»
Occulo Bio - CB Insights
Explore {Occulo Bio's key management people. Discover current leadership team members including founders, CEO, other executives and board directors. Occulo Bio CEO, Founder, โฆSee details»
Occulobio Security Rating - SecurityScorecard
View Occulobio's cyber security risk rating against other vendors' scores. Explore cyber risks, data breaches, and cybersecurity incidents involving OcculobioSee details»
Scientist Position Occulo Bio LLC - bpb-us-e1.wpmucdn.com
Occulo Bio is an equal opportunity employer with a strong commitment to diversity and inclusion. We do not discriminate on the basis of race, color, religion, sex, age, national origin, sexual โฆSee details»
Occulo Bio LLC Company Profile - Dun & Bradstreet
Occulo Bio LLC. Get a D&B Hoovers Free Trial. Overview Company Description:? Key Principal: Karl Griswold See more contacts Industry: Scientific Research and Development Services , โฆSee details»
Yongliang Fang - Occulo Bio LLC - LinkedIn
Experience: Occulo Bio LLC · Education: Dartmouth College · Location: Hanover · 500+ connections on LinkedIn. View Yongliang Fangโs profile on LinkedIn, a โฆSee details»
Weird and wonderful case studies: Real-world solutions for โฆ
Prior to joining Doer Biologic, Dr. Fang was the co-founder and Chief Operating Officer for Occulo Bio LLC and Lyticon LLC. Dr. Yongliang Fang earned his Ph.D. degree in Bioengineering from โฆSee details»
Occulo Bio - CB Insights
Occulo Bio's latest funding round was a Unattributed for $12.8M on November 17, 2017. Date. Round. Amount. Investors. Valuation. Valuations are submitted by companies, mined from โฆSee details»
ใๅญฆๆฏๆฅๅใ5ๆ20ๆฅ Discovery and development of therapeutic โฆ
Yongliang Fang, Ph.D. Co-Founder and Chief Operating Officer at Occulo Bio LLC. ๆฅๅๆถ้ด๏ผ2019ๅนด5ๆ20ๆฅ10:00am . ๆฅๅๅฐ็น๏ผๅทฅ็จๆฅผB506ๅฎค . ๆฅๅไบบ็ฎๅ๏ผ Dr. Fang received his โฆSee details»
OBIO - LinkedIn
OBIO | 12,177 followers on LinkedIn. Addressing the needs of the next generation of companies developing innovative human health products. | Founded in 2009, OBIO® is a not-for-profit, โฆSee details»
Home | OUTbio
OUTbio November 2024 Event Thursday, November 21st from 5:00-7:00 pm ET. Vertex, 11 Fan Pier Boulevard Boston, MA 02210See details»